NCT03474094
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03474094
Title Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy (RT-Immune)
Acronym RT-Immune
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | FRA

Facility Status City State Zip Country Details
Institut Bergonie Bordeaux France Details
Centre Oscar Lambret Lille France Details
Centre Léon Bérard Lyon 69008 France Details
Institut Claudius Regaud Toulouse 31059 France Details
Institut Gustave Roussy Villejuif 94805 France Details
Royal Marsden Hospital London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field